As a natural home remedy, we now know ginger as a tea for colds, sore throats and coughs or for motion sickness. But there is much more potential in the sharp roots from the tropics.
Research teams around the world are working to better understand the ingredients of Ginger and their versatile effects on the human organism. Current studies are now showing promising results for tumor patients. Tests on cell cultures have shown three advantages: Ginger is anti-inflammatory; it inhibits the division of cancer cells and has a chemopreventive effect. UNIFONTIS uses these findings from cancer research in a ginger-based therapy.
In the history of medicine, Ginger has been an established therapeutic agent for around 2000 years. There are recipes in Chinese medicine as well as in European or Arabic medicine with Ginger as a remedy for ailments of the digestive system, eyes or coughs.
Today we know more about the versatile effects of Ginger. Studies show: Ginger is antioxidant, i.e. it has the ability to scavenge oxygen radicals which damage our cells. Mutations that can lead to cancer are thus combated as they arise. Ginger is anti-inflammatory. The so-called gingerols and shogaols are responsible for this. They inhibit the production of various enzymes that promote inflammation. (Incidentally, both substances are also responsible for the sharp taste in Ginger.)
Ginger is pro-apoptotic, which means that it triggers programmed cell death. In animal studies, a specific decrease in the number and size of pancreatic tumors could be observed. In addition, ginger reduces nausea during chemotherapy and has a positive effect on the intestinal mucosa by promoting the growth of healthy intestinal bacteria.
Research teams in different countries are working to better understand the multifaceted effects of the ingredients on human. A full scientific analysis of the effect is still pending.
UNIFONTIS | Prof. Dr. med. Joachim Drevs
Specialist for internal medicine
Additional qualification in hematology / private oncology doctor
Fax: +49 (0)5305-1317
Central contact number:
© Copyright UNIFONTIS. Alle Rechte vorbehalten.